HMO supplement

DIETARY_SUPPLEMENT2 trials

Sponsors

Société des Produits Nestlé (SPN)

Conditions

Low Birthweight InfantPremature Infant

Unknown Phase

Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides (HMOs) in Preterm Infants

CompletedNCT03607942

Société des Produits Nestlé (SPN)Premature Infant

Start: 2018-08-06End: 2022-11-30Updated: 2023-03-21

Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)

RecruitingNCT06212427

Société des Produits Nestlé (SPN)Low Birthweight Infant, Premature Infant

Start: 2023-11-20End: 2026-02-28Target: 188Updated: 2025-12-08

Related Papers

Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides: The First Double-Blind, Randomized, Controlled Trial in Pre-term Infants

Frontiers in Pediatrics2022-04-2522 citations